MAPK-activated protein kinase 2 contributes to Clostridium difficile-associated inflammation

Area of Science:

• Gastroenterology
• Immunology
• Microbiology

Background:

• Clostridium difficile infection (CDI) causes significant intestinal inflammation and epithelial injury.
• The regulation of inflammatory responses in CDI is not fully understood.
• Previous research linked C. difficile toxin A (TcdA) to p38 kinase activation and interleukin-8 (IL-8) release.

Purpose of the Study:

• To investigate the role of phosphorylated mitogen-activated protein kinase (MAPK)-activated protein kinase 2 (pMK2), a p38-dependent inflammation mediator, in CDI.
• To determine if MK2 kinase activity is essential for toxin-induced cytokine production.
• To assess the in vivo activation of the p38-MK2 pathway in animal models and human CDI cases.

Main Methods:

• Cultured intestinal epithelial cells were exposed to C. difficile toxins TcdA and TcdB.
• p38 and MK2 activation, as well as cytokine release (IL-8, GROα), were measured.
• pMK2 levels were assessed in the intestines of infected hamsters and mice, and in human stool samples.

Main Results:

• TcdA and TcdB toxins activated p38-dependent MK2 in intestinal epithelial cells.
• MK2 activity was required for toxin-induced release of IL-8 and GROα.
• Elevated pMK2 levels were detected in infected animals and correlated with toxigenic C. difficile in human samples.

Conclusions:

• MK2 kinase is activated by C. difficile toxins and regulates pro-inflammatory cytokine expression.
• The p38-MK2 pathway is activated during C. difficile infection in vivo.
• This pathway is a significant contributor to intestinal inflammation in CDI and a potential therapeutic target.